At the imminent Microdose Virtual Psychedelic Conference, Simeon Schnapper and his comrades from the JLS Fund are set to play instrumental roles
Schnapper alongside Charley Wininger will function as a panelist for the “Beyond Mental Health” discussion. JLS Fund, birthed from an inclination to merge science, technology, and neurology, specifically targets investments in plant-based and psychedelic remedies. This particular investment approach aims to address diseases and enhance wellbeing. The focus extends to developing medicines for challenging mental and physical illnesses and incorporating technologies that expedite these treatments.
Psilera, one of JLS Fund’s investments, pioneers the approach of utilizing psychoactive natural components to pave the way for innovative neurological treatments.
Embodying Change Summit and Forthcoming Events
In the up-and-coming Embodying Change Summit happening this September 27-29, 2024, in New York City, Schnapper will present his insights and knowledge on psychedelic investment. This elite event gathers innovators, financiers, and lawmakers who aim to work jointly on projects for potential colossal transformations.
Future events also consist of a chain of intimate talks involving Schnapper and JLS Fund executives such as Lindsay Hoover and Michael Gruber. Topics that will be discussed include Investor State of Mind and the Psychedelics & Technology Investment Prospect.
As for its line-up of investments, the JLS Fund has gained significant attention in the media and has been featured in several press outlets, including Lucid News, Khaner Global, Double Blind, Benzinga, and Business Insider. For example, Business Insider has hailed JLS as a top–tier venture capitalist in the psychedelic sector, while Gilgamesh, another venture backed by the JLS, has been recognized as one of the fastest-growing startups in the industry.
JLS Fund is cutting-edge in the realm of psychedelic medicine and technology investments. Their proactive involvement and contributions to industry scenes, such as the Microdose Virtual Psychedelic Conference and the Embodying Change Summit, highlight the fund’s significant impact in this nascent yet promising sector.
